EDIT vs MCD
Editas Medicine Inc (EDIT) versus McDonald’s Corporation (MCD) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
McDonald’s Corporation (MCD) is a restaurants company listed on NYSE. It is led by Chris Kempczinski.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported MCD revenue for 2024-12-31 was $25.92B. Net income was $8.22B. Revenue was up 1.7% from 2023-12-31 to 2024-12-31. MCD currently screens at market cap $201.66B and trailing P/E 23.4.
EDIT currently screens at market cap $375.2M. MCD currently screens at market cap $201.66B and trailing P/E 23.4.
Not investment advice. Open the EDIT and MCD stock pages for the full models.
Not investment advice.